Whitehawk Therapeutics Statistics

NASDAQ: WHWKHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.47+0.06 (+1.76%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

After hours: 3.47 0.00%

Whitehawk Therapeutics by the numbers

Whitehawk Therapeutics has a market capitalization of $197.8 million based on 57.01M shares outstanding. With trailing EPS of $-1.14, Whitehawk Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 18.7% below its 50-day average and 8.4% below its 200-day average.

Average daily trading volume is 371.36K shares, or about $1.3 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

WHWK valuation vs. peer median

WHWK compared with the median of 8 peer companies
Metric	WHWK	Peer median	Difference
Market cap	$197.82M	$187.41M	+6%
Avg. volume	371.36K	240.15K	+55%

Peer median across 8 companies: ELDN, NGEN, ADAG, ADCT, YARW, RNAC, ANTX, ORMP.

Valuation

Market cap: $197.82M
P/E (TTM): —
Forward P/E: —
EPS (TTM): $-1.14
Shares outstanding: 57.01M

Price and trading

Previous close: 3.41
Open: 3.37
Day range: 3.33 – 3.52
52-week range: 1.87 – 5.50
52-week change: +53.60%
50-day moving average: 4.27
200-day moving average: 3.79
Beta: —
Volume: 248.60K
Average volume: 371.36K

Dividends and events

Annual dividend: None
Dividend yield: —
Ex-dividend date: —
Next earnings date: Nov 5, 2026

Additional statistics

Market Cap: 197.82M
Forward Pe: -3.51
Eps: -1.14
Dividend Yield: 0.00%
Dividend Rate: 0.00
Week52 High: 5.50
Week52 Low: 1.87
Avg Volume: 371.36K
Shares Outstanding: 57.01M
Ma50: 4.27
Ma200: 3.79
Earnings Date: Nov 5, 2026
Pct From52w High: -36.85%
Pct From52w Low: 85.56%